Literature DB >> 24881574

Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity.

P Faure1, S Tolu2, S Valverde2, J Naudé2.   

Abstract

Midbrain dopamine (DA) neurons play a central role in a wide range of behaviors, from attention and motivation to motor control and reinforcement. The release of DA is modulated by a number of factors, and its deregulation has been implicated in multiple psychiatric disorders, such as addiction. In particular, nicotinic acetylcholine receptors (nAChRs) are key modulators of DA cells. Nicotine, the main addictive component in tobacco, strongly interacts with these receptors in the midbrain DA systems, resulting in reinforcing effects that are at the core of tobacco addiction. nAChRs are virtually expressed on every cell of the DA system, both at pre-, post- and extra-synaptic locations. The complex issue of interpreting the role of the large portfolio of different nAChR subtypes expressed on ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) neurons, and especially their role in defining functional DAergic subpopulations, is far from being solved. In this review we will try to provide the reader with an integrative view of the nicotinic modulation of DA neurons and its influence at the cellular, systemic and behavioral levels (exploratory behavior), as well as its implication in the reinforcing effects of nicotine.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  VTA; dopamine; nAChRs; nicotine; substantia nigra

Mesh:

Substances:

Year:  2014        PMID: 24881574     DOI: 10.1016/j.neuroscience.2014.05.040

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

Review 1.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

2.  Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence.

Authors:  Lingjun Zuo; Yunlong Tan; Chiang-Shan R Li; Zhiren Wang; Kesheng Wang; Xiangyang Zhang; Xiandong Lin; Xiangning Chen; Chunlong Zhong; Xiaoping Wang; Jijun Wang; Lu Lu; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-07-30       Impact factor: 3.568

3.  Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference.

Authors:  Gofarana Wilar; Yasuharu Shinoda; Toshikuni Sasaoka; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

4.  Nicotine drug discrimination and nicotinic acetylcholine receptors in differentially reared rats.

Authors:  Charles S Bockman; Wanyun Zeng; Jamie Hall; Beth Mittelstet; Liz Schwarzkopf; Dustin J Stairs
Journal:  Psychopharmacology (Berl)       Date:  2018-02-21       Impact factor: 4.530

Review 5.  Nicotinic Acetylcholine Receptor Signaling in the Hypothalamus: Mechanisms Related to Nicotine's Effects on Food Intake.

Authors:  Cali A Calarco; Marina R Picciotto
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

6.  Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys.

Authors:  Sarah L Withey; Michelle R Doyle; Jack Bergman; Rajeev I Desai
Journal:  J Pharmacol Exp Ther       Date:  2018-05-21       Impact factor: 4.030

7.  Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Authors:  Brandon J Henderson; Teagan R Wall; Beverley M Henley; Charlene H Kim; Weston A Nichols; Ruin Moaddel; Cheng Xiao; Henry A Lester
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

8.  Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

Authors:  Vanda Andrade; M Luísa Mateus; M Camila Batoréu; Michael Aschner; Ap Marreilha Dos Santos
Journal:  EC Pharmacol Toxicol       Date:  2017-01-23

9.  r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.

Authors:  Joshua S Beckmann; Andrew C Meyer; M Pivavarchyk; David B Horton; Guangrong Zheng; Andrew M Smith; Thomas E Wooters; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Neurochem Res       Date:  2015-07-31       Impact factor: 3.996

Review 10.  Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement.

Authors:  Carole Morel; Sarah Montgomery; Ming-Hu Han
Journal:  Eur J Neurosci       Date:  2018-10-15       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.